Commerce RI approves incentives for new Amgen biomanufacturing facility

PREPARING FOR SUCCESS: Amgen Rhode Island senior associates Devon Zayas, left, and Scott Lyons conduct a safety check prior to using a bioreactor at the company’s West Greenwich facility. / PBN PHOTO/
RUPERT WHITELEY
PREPARING FOR SUCCESS: Amgen Rhode Island senior associates Devon Zayas, left, and Scott Lyons conduct a safety check prior to using a bioreactor at the company’s West Greenwich facility. / PBN FILE PHOTO/RUPERT WHITELEY
PROVIDENCE – The R.I. Commerce Corp on Tuesday approved approximately $8.2 million in incentives with the possibility for up to $9.4 million in incentives for Immunex Rhode Island Corp., a subsidiary of Amgen Inc., for the construction of an approximately $165 million “next-generation” biomanufacturing facility in West Greenwich. The plant will be built on the current…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -